Haemonetics
181 hedge funds and large institutions have $2.21B invested in Haemonetics in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 63 increasing their positions, 73 reducing their positions, and 10 closing their positions.
110% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 10
6% more funds holding
Funds holding: 170 → 181 (+11)
0.45% more ownership
Funds ownership: 104.4% → 104.85% (+0.45%)
8% less capital invested
Capital invested by funds: $2.41B → $2.21B (-$201M)
14% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 73
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$49.8M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.4M |
| 3 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
+$7.28M |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$6.2M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$5.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PP
Prudential plc
London, England,
United Kingdom
|
-$17.3M |
| 2 |
Neuberger Berman Group
New York
|
-$15.8M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$14.2M |
| 4 |
SCM
Snyder Capital Management
San Francisco,
California
|
-$11.1M |
| 5 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$9.29M |
HAE Hedge Fund Activity: Q2 2015 in Review
181 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q2 2015, worth a combined $2.21B — down 8.3% from $2.41B a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new HAE positions and 10 closed out — a net gain of 11 holders — while 63 added to existing stakes and 73 trimmed.
The largest buyer was Wells Fargo, adding an estimated $49.8M. The largest seller was Prudential plc, cutting an estimated $17.3M.
- 181 institutional investors held Haemonetics (HAE) as of Q2 2015, up from 170 in Q1 2015.
- Funds reported $2.21B of Haemonetics stock for Q2 2015, down 8.3% quarter-over-quarter.
- 21 funds opened new Haemonetics positions in Q2 2015 and 10 closed out, a net change of +11 holders.
- The largest Haemonetics buyer in Q2 2015 was Wells Fargo, an estimated $49.8M added.
- The largest Haemonetics seller in Q2 2015 was Prudential plc, an estimated $17.3M sold.
Based on aggregated 13F filings for Q2 2015.